| In
2001, a group of prominent laser scientists, leading
clinicians, and business executives came together with
a shared vision. They would create a new science and
breakthrough products to fulfill the promise of laser
medicine. No more big dumb "boxes." No more
hype. They vowed to bring a new intelligence to solve
the problems of aging and sun damaged skin. The
Reliant team has created a breakthrough in laser delivery
by focusing on Fraxel laser treatment. In the hands
of clinicians worldwide, Reliant's proprietary technology
platform is poised to change the treatment paradigm
to a new standard of care.
Today,
the newly formed Reliant (the integration of RTI Holdings
and Reliant Technologies) employs a team of 150 professionals
in Mountain View, California. The company released
the revolutionary Reliant Fraxel SR laser in the fourth
quarter of 2004. Reliant is positioned for growth
and prepared to meet the challenge of becoming the
new market leader in aesthetic laser medicine and
surgery.
Reliant
Technologies is supported by both individual and institutional
funding, including significant financial and board
support from Three Arch Partners and Meritech Capital
Partners. Three Arch Partners is one of the leading
medical device and service focused venture firms in
the world. Since inception, Three Arch has focused
on identifying and creating new healthcare companies
in markets with significant unmet clinical or infrastructure
needs. Meritech Capital Partners is a leading provider
of late-stage venture capital to the most promising
private technology companies. Meritech seeks to lead
investments in the portfolio companies of leading
early-stage venture capital firms. Reliant has also
secured debt financing from Pinnacle Venture Partners
and Comerica Bank. www.reliant-tech.com |
